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Abstract
Developments in the field of phosphoproteomics have been fueled by the need simultaneously to
monitor many different phosphoproteins within the signaling networks that coordinate responses
to changes in the cellular environment. This article presents a brief review of phosphoproteomics
with an emphasis on the biological insights that have been derived so far. 
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Although many biochemical mechanisms are involved in
cellular signaling, reversible phosphorylation of serine,
threonine, and tyrosine residues is the one most commonly
used in mammalian cells. Protein kinases are one of the largest
gene families in humans and mice, accounting for 1.7% of the
human genome [1,2], and up to 30% of all proteins may be
phosphorylated [3]. Traditional biochemical and genetic
analyses of phosphoproteins, and of the kinases and
phosphatases that modify them, have provided a wealth of
information about signaling pathways. These approaches,
which typically focus on one protein at a time, are, however,
not readily amenable to understanding the complexity of
protein phosphorylation or how individual phosphoproteins
function in the context of signaling networks. The availabil-
ity of genome databases and advancements in analytical
technology, especially mass spectrometry, has made it
possible to study many phosphoproteins and phosphorylation
sites at once. The term ‘phosphoproteomics’ describes a
sub-discipline of proteomics that is focused on deriving a
comprehensive view of the extent and dynamics of protein
phosphorylation. While phosphoproteomics will greatly
expand knowledge about the numbers and types of phospho-
proteins, its greatest promise is the rapid analysis of entire
phosphorylation-based signaling networks. 
Phosphoproteomic methods
Current methods for analysis of the phosphoproteome rely
heavily on mass spectrometry and ‘phosphospecific’ enrichment
techniques. Emerging technologies that are likely to have
important impacts on phosphoproteomics include protein
[4] and antibody [5] microarrays, and fluorescence-based
single-cell analysis [6]. While these methods have the poten-
tial for high sensitivity and high throughput, they require prior
knowledge of particular phosphoprotein targets. In contrast,
mass-spectrometry-based approaches both allow large-scale
analysis and provide the ability to discover new phospho-
proteins. The speed, selectivity, and sensitivity of mass
spectrometry also provide important advantages over bio-
chemical methods for the analysis of protein phosphorylation
[7-9]. Because many phosphoproteins, especially signaling
intermediates, are low-abundance proteins phosphorylated at
sub-stoichiometric levels, a considerable amount of effort has
been devoted to the development of phosphospecific
enrichment  methods that are compatible with, or directly
coupled to, mass spectrometry. These methodological
approaches have been described in a number of recent reviews
[7,8,10-13], and current methods are summarized in Table 1. 
Phosphoproteomics is a rapidly moving field. For example,
advances in mass spectrometry, including the use of Fourier
transform ion cyclotron resonance instruments, have recently
been applied so as to improve the sensitivity and accuracy of
phosphoproteomic experiments [14]. It is likely that addi-
tional technological improvements will occur over the next
few years. A recent, and very important, advance has been the
incorporation of quantitative mass spectrometry methods
into phosphoproteomics. For example, information about thedynamics of protein phosphorylation is often more informa-
tive than efforts directed solely at expanding the ‘parts list’ of
signaling proteins. Identification of proteins or phosphoryla-
tion sites that change in response to receptor activation vali-
dates them as important components in signaling through
that receptor. 
Quantitative methods for mass spectrometry-based phos-
phoproteomics rely on the use of heavy isotopes and fall into
three general categories: in vitro labeling of phosphoamino
acids, in vitro labeling of proteins and peptides, and in vivo
metabolic labeling. The basic principle of all three involves
labeling peptides from one sample (control cells, for example)
with a heavy isotope. This sample is then mixed with an unla-
beled sample (from stimulated cells, for example) and the two
are analyzed simultaneously. The ability of mass spectrome-
ters to resolve the normal and isotopically labeled versions
of the same peptide allows direct comparison of the amount
of peptide in each sample. If the labeled peptide is a phos-
phopeptide, this method can be used to determine changes
in the level of phosphorylation.
Several methods for in vitro labeling of phosphoamino acids
with isotopically tagged moieties have been reported (for a
list of methods discussed here, see Table 2). Phosphoprotein
isotope-coded affinity tag (PhIAT) involves the introduction
of two isotopic forms of biotin-tagged dithiols into phospho-
serine and phosphothreonine residues [15]. Phosphoprotein
isotope-coded solid-phase tag (PhIST) involves the simulta-
neous capture and labeling of phosphopeptides using solid-
phase reagents [16]. A third method, -elimination/Michael
addition with DTT (BEMAD), utilizes incorporation of
normal or deuterated dithiothreitol followed by enrichment
of labeled peptides by thiol chromatography [17,18]. All
these methods utilize -elimination/Michael addition chem-
istry to derivatize the phosphorylated amino acids; but this
derivatization method is limited in that it cannot modify
phosphotyrosine residues and also modifies sites of O-linked
addition of N-acetylglucosamine [18].
In vitro methods for labeling peptides at sites other than
phosphoamino acids include isotope-coded affinity tagging
(ICAT), which labels cysteines with biotin derivatives that
allow affinity enrichment of the labeled peptides [19].
Although limited to the analysis of phosphopeptides that
also contain a cysteine residue, ICAT has been used to study
phosphorylation of the epidermal growth factor (EGF)
receptor [20]. The iTRAQ method (commercially available
from Applied Biosystems, Foster City, USA) involves isotopic
labeling of amine groups, allowing uniform labeling of all
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Table 1
Methods for the enrichment of phosphoproteins and phosphopeptides for analysis by mass spectrometry
Method Comments References 
Chemical modification
Affinity tagging Phosphorylated amino acids are derivatized by -elimination or carbodiimide to introduce tags;  [46,47]
-elimination strategy is limited to P-Ser and P-Thr, and also occurs with O-glycosylated residues.
Fluorous affinity tagging Perfluoroalkyl groups are selectively coupled to P-Ser and P-Thr using -elimination; modified  [48]
peptides are enriched with fluorous-functionalized stationary phase. This method is highly selective 
for derivatized peptides.
Phosphospecific proteolyis Chemical modification of P-Ser and P-Thr introduces lysine analogs and cleavage by lysine-specific  [49]
proteases. This method allows direct identification of phosphorylation site without sequencing 
the phosphopeptide.
Thiophosphorylation and  Proteins are phosphorylated with ATPS; thiophosphates are alkylated to form linkages with biotin  [50]
affinity tagging or solid supports. This method requires in vitro phosphorylation and most kinases utilize ATPS poorly.
Bio-orthogonal affinity  Analog-specific kinases are used selectively to phosphorylate substrates in vitro or in vivo; the phosphate  [51]
purification analogs are then derivatized to generate a hapten for immunoprecipitation. This method requires 
expression and/or isolation of an engineered kinase.
Direct enrichment
Anti-phosphotyrosine  Anti-P-Tyr antibodies have proven very useful for the enrichment of P-Tyr-containing proteins; they  [31,33,52,53]
antibodies have been used alone or in combination with IMAC. They have been used to enrich P-Tyr peptides.
Anti-phosphoserine and anti- Anti-P-Ser and anti-P-Thr antibodies have been used, but currently are less useful than anti-P-Tyr  [54-56]
phosphothreonine antibodies antibodies.
Immobilized metal affinity  Introduction of an esterification step greatly enhances the selectivity of this method, which is very [29,57,58]
chromatography (IMAC) useful, has been widely used and can be automated.
Cation exchange Strong cation exchange chromatography has been used for the large-scale identification of  [34]
phosphorylation sites. This method selects for peptides phosphorylated on a single residue.
Abbreviations: P-Ser, phosphoserine; P-Thr, phosphothreonine; P-Tyr, phosphotyrosine.peptides in a sample. The iTRAQ method has been coupled
with phosphotyrosine peptide enrichment and immobilized
metal affinity chromatography (IMAC) to study the dynamics
of phosphotyrosine-mediated EGF receptor signaling [21].
The third, and most widely used, method for isotopically
labeling peptides involves metabolic labeling of cultured
cells with amino acids (usually lysine and arginine) contain-
ing heavy isotopes. Stable isotope labeling by amino acids in
cell culture (SILAC) is used in conjunction with mass spec-
trometry for the measurement of changes in protein expres-
sion and post-translational modifications (Figure 1) [22].
SILAC has been coupled with the use of anti-phosphotyro-
sine antibodies to study tyrosine phosphorylation following
activation of the receptors for EGF [23,24], fibroblast growth
factor [25], and insulin [26]. SILAC has been coupled with
IMAC to analyze the signaling involved in the yeast
pheromone response [14] and in a targeted way to study the
temporal phosphorylation of the 2-adrenergic receptor [27]
and the ERK/p90rsk protein kinase signaling pathway [28]. 
Expanding the signaling parts list
Much of the current literature on phosphoproteomics is
devoted to methods development. Technological advance-
ments have expanded the capabilities of phosphopro-
teomics, but its ultimate impact depends on the biological
meaning that can be generated from phosphoproteomic
data. Even though its potential is just now being realized, a
number of phosphoproteomic studies have already provided
important new insights into cellular signaling. 
A major application of phosphoproteomics has been the dis-
covery of phosphoproteins not previously known to be
involved in cellular signaling and the discovery of new phos-
phorylation sites in known signaling proteins. As enzymatic
catalysis by protein kinases is the only known physiological
mechanism for phosphorylation of serine, threonine, and
tyrosine residues, and as most kinases are induced in cell
signaling, any phosphorylated protein is potentially involved
in signal transduction. Thus, there have been a number of
large-scale screens for phosphoproteins and phosphoryla-
tion sites. Studies involving the enrichment of phosphopep-
tides followed by the identification of phosphorylation sites
by tandem mass spectrometry have been carried out with
yeast [29], human sperm [30], human T cells [31], murine
B-lymphoma cells [32], human Jurkat cells, murine 3T3
cells, and human cancer cell lines [33]. This type of study
provides four kinds of new information: a list of known
phosphoproteins that are expressed in a particular cell type;
the identification of novel phosphorylation sites in previ-
ously known phosphoproteins; details of the phosphoryla-
tion of known proteins that have not previously been shown
to be phosphorylated; and the identification of the phospho-
rylation of completely novel proteins.
Large-scale phosphoprotein and phosphopeptide screens like
those described above [29-33] have been very effective in
identifying large numbers of phosphoproteins and phosphory-
lation sites. The utility of this information is, however, often
limited by a lack of biological context, especially for phospho-
proteins with no known function. A targeted approach to
examining phosphoproteins in specific subcellular organelles
helps to overcome this limitation. Examples include phospho-
proteomic analysis of HeLa cell nuclear proteins [34], murine
synaptosomes [35], murine postsynaptic densities (that area
of a postsynaptic membrane where neurotransmitter recep-
tors and ion channels are clustered) [36], and Arabidopsis
plasma membranes [37]. The underlying assumption in these
targeted experiments is that the phosphorylation identified
play a role in signaling pathways that regulate the function of
that organelle. So far, this assumption seems to hold quite
well, as many of the phosphorylation sites that were identi-
fied were in proteins known to be associated with those
organelles. Other approaches have targeted cells in defined
states, including the identification of phosphorylation sites
in proteins from capacitated human sperm [30] and phos-
photyrosine proteins from activated T cells or chronic
myelogenous leukemia cells treated with Gleevec, an
inhibitor of the BCR-Abl protein kinase [38]. 
Additional functional insights derived from large-scale
phosphoproteomic experiments are estimates of the contri-
butions of different protein kinases to overall protein
phosphorylation. Phosphopeptide sequences identified in
phosphoproteomic screens have been analyzed with bioin-
formatic software tools that predict consensus phosphoryla-
tion sites for a variety of protein kinases (Table 3). Analysis
of the large dataset (2,002 phosphorylation sites) from
growing HeLa cell nuclear proteins with the Scansite
program [39] showed that kinases that target serine and
threonine residues followed by proline residues (for
example, cyclin-dependent kinases, Cdks, and mitogen-
activated protein (MAP) kinases) and acidophilic kinases,
such as casein kinases, accounted for 77% of the total sites
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Table 2 
Quantitative mass spectrometry methods for analyzing
phosphopeptides and phosphoproteins
Method Abbreviation Reference
Phosphoprotein isotope-coded affinity tag PhIAT [15]
Phosphoprotein isotope-coded solid phase tag PhIST [16]
-elimination/Michael addition with DTT BEMAD [17-18]
Isotope coded affinity tag ICAT [19-20]
Isotope tagged amine-reactive reagents  iTRAQ
TM [21]
Stable isotope labeling with amino acids in  SILAC [22-28]
cell culture[34]. There were no tyrosine phosphorylation sites detected
in this study, consistent with the low levels of this modifica-
tion (<1%) thought to be present in most cells. A relative
paucity of tyrosine phosphorylation sites was also observed
in phosphoproteomic analyses of the WEHI-231 B-lym-
phoma cell line [32] and Arabidopsis plasma membranes
[37]. Bioinformatic analysis of 289 synaptosomal phospho-
rylation sites with Scansite and NetPhosK [40] led to the
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Figure 1
Monitoring changes in protein phosphorylation by the SILAC method. (a) Schematic outline of the method. Separate cultures of cells are grown in
normal medium (12C6-arginine) or in medium containing arginine labeled at all six carbons with 13C (13C6-arginine). The cells in normal medium are left
unstimulated whereas cells in the 13C-arginine medium are stimulated with an agent that activates signaling. The cells are harvested and equal amounts of
lysate protein mixed together. In most cases, steps to enrich phosphoproteins, enrich phosphopeptides after trypsin digestion, or both, are needed to
detect low-abundance phosphopeptides. The peptides are resolved by reverse-phase liquid chromatography (LC) followed by online mass spectrometry
(MS). Tandem mass spectrometry (MS/MS) data are used for automated database searching to identify peptides (and their corresponding protein) and to
detect phosphopeptides (typically by detecting neutral loss of phosphate during MS/MS). In many cases, the MS/MS data can also be used to assign site(s)
of phosphorylation. Once peptides of interest are identified, the relative amounts of peptide derived from the unstimulated cells (grown in normal
medium) and the stimulated cells (grown in 13C-arginine medium) are determined from high-resolution MS scans. (b,c) Quantitation of peptides. (b) A
total ion chromatogram of a protein digest eluted from a reverse-phase column and analyzed by mass spectrometry. The peaks represents the total ion
signal from individual peptides. (c) shows high-resolution MS scans of a non-phosphorylated peptide (left panel) and a different phosphorylated peptide
(right panel), which was identified from MS/MS scans (not shown), eluted from the reverse-phase column at different retention times. The left-hand panel
is a magnified MS scan showing the normal and 13C-arginine-labeled versions of the non-phosphorylated peptide with mass-to-charge ratio (m/z) of 588.
Even though the 13C-arginine peptide has a mass that is 6 Da higher than the normal peptide, m/z differs by only 3 (m/z 591) because the peptide has two
positive charges (2+). Both peptides appear as a series of isotopic peaks as a result of the natural abundance of heavy isotopes. The relative amounts of
the normal and 13C-arginine peptides are determined by comparing the area under the monoisotopic peaks (the tallest peak in each series) of each
peptide. In this example experiment, the amount of this non-phosphorylated peptide was not affected by stimulation and the ratio of the two peptides is
1.0. The right-hand panel shows the same data for the phosphopeptide of m/z 628 that eluted at 35 minutes. In this case, the ratio of the normal peptide
to the 13C-arginine peptide is 0.2, showing that the amount of phosphopeptide increased fivefold following stimulation.
12C6-arginine 13C6-arginine
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(c)conclusion that a small number of protein kinases phospho-
rylate many synaptic proteins and that each synaptic phos-
phoprotein is phosphorylated by many kinases [35]. This
analysis allowed the construction of a kinase-substrate
network map that could be superimposed onto the protein-
protein interaction network of the N-methyl D-aspartate C
(NMDA) receptor complex (one of the receptors for the neuro-
transmitter glutamate). This network model predicts an
important role for proximity and scaffolding proteins in
mediating signaling through the complex.
The advent of phosphoproteomic methods for the large-scale
identification of phosphorylation sites has generated a criti-
cal need for easy and effective ways to disseminate informa-
tion derived from phosphoproteomic studies to the signal
transduction research community. Datasets obtained in
large-scale screens are likely to include information about
phosphorylation sites in proteins that are the main focus of
individual laboratories. Without easy ways to search the
large datasets, it is difficult for such laboratories to take
advantage of the information. Fortunately, there are several
ongoing efforts to incorporate phosphorylation-site informa-
tion derived from large-scale phosphoproteomics experi-
ments into searchable databases. These efforts include the
Phosphosite database [41], the Swiss-Prot database [42,43],
and the Phospho.ELM database [44] (see Table 3).
Quantitative phosphoproteomics: powerful
methods for analyzing the dynamics of signaling
networks
The combination of quantitative mass spectrometry and
phosphoproteomics has generated powerful technologies for
studying cellular signaling. The phosphoproteomic screen-
ing approaches described here have provided new insights
into the complexity of protein phosphorylation. The rele-
vance of individual phosphorylation sites detected in these
studies to particular signaling pathways is, however, often
unknown. The ability to monitor changes in phosphorylation
that occur in response to the perturbation of a signaling
pathway allows identification of phosphoproteins relevant to
that pathway. Phosphospecific antibodies are very sensitive
and useful probes for analyzing changes in phosphorylation
of specific sites. They do, however, require prior knowledge
of the phosphorylation site and it is challenging to monitor
large numbers of phosphorylation sites simultaneously.
Quantitative phosphoproteomics has a sensitivity that
approaches that of phosphospecific antibodies but can be
used to identify novel phosphoproteins and to monitor hun-
dreds or thousands of individual phosphorylation sites in a
single experiment. 
Quantitative proteomics methods have been used in a tar-
geted way to monitor phosphorylation of individual proteins.
A combination of SILAC and IMAC was used to analyze
agonist-induced phosphorylation of the 2-adrenergic recep-
tor [27]. The simultaneous monitoring of multiple sites
allowed identification of the relevant in vivo phosphorylation
sites and the discovery that different agonists (for example,
isoproterenol and dopamine) induce differential phosphory-
lation of individual sites. SILAC was also used to monitor in
vivo the kinetics of EGF-induced phosphorylation of six
phosphotyrosine residues in the EGF receptor [45]. The
results showed that the kinetics of phosphorylation of the
tyrosine residues correlated with the preferential association
of the receptor with individual binding partners,  such as
growth factor receptor bound protein 2 (Grb2) and Src
homology 2 domain-containing transforming protein (Shc).
A second major application of quantitative phosphopro-
teomics has been in studying the dynamics of phosphorylation
and the assembly of signaling complexes. A combination of
SILAC and anti-phosphotyrosine immunoprecipitation was
used to examine phosphotyrosine-dependent signaling net-
works induced by EGF stimulation of HeLa cells [24]. Of the
202 proteins detected, which were either phosphotyrosine
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Table 3
Useful websites for phosphoproteomics
Name Comments      URL Reference
Phosphorylation-site databases
Phosphosite Searchable by protein name to look for known phosphorylation sites [http://www.phosphosite.org] [41]
Swiss-Prot Protein annotations include sites of phosphorylation and other  [http://us.expasy.org/sprot] [43]
post-translational modifications
Phospho.ELM Searchable by protein name, kinase substrates, or SH2-binding sites [http://phospho.elm.eu.org] [44]
Phosphorylation-site prediction
Scansite Scans for kinase motifs derived from peptide library phosphorylation data [http://scansite.mit.edu] [59]
NetPhosK Produces neural network predictions of specific kinase phosphorylation sites [http://www.cbs.dtu.dk/services/NetPhosK] [60]
ProSite Scans for kinase consensus motifs derived from the literature.  [http://us.expasy.org/prosite] [61]
A limited number of kinase motifs are includedproteins or proteins that co-precipitated with phosphotyrosine
proteins, the levels of 81 were elevated by 1.5-fold or more
following EGF stimulation. In addition to monitoring the
activation of tyrosine phosphorylation, these experiments
detected and quantitated proteins that associate with phos-
photyrosine proteins through Src homology 2 (SH2)
domains and other binding motifs. For example, temporal
changes in the phosphorylation of the EGF receptor corre-
lated with the co-precipitation of proteins known to interact
with it, such as Grb2 and Shc. While nearly all of the proteins
known to be associated with EGF receptor signaling were
identified in these experiments, many additional proteins
that were not previously known to be associated with this
pathway were also identified. For example, the time-dependent
recruitment of a set of RNA-binding proteins suggested a
novel role for EGF receptor signaling in mRNA processing
and transport. Six novel EGF-dependent proteins with no
known function were also identified in these experiments.
Quantitative mass spectrometry was used to compare the
time courses of their association with the anti-phosphotyrosine
complex with the time course of EGF receptor activation;
this comparison allowed the assignment of functions for
these proteins in early, membrane-proximal events or in
later events such as cytoskeletal reorganization or endosomal
trafficking. This report [24] provides the first example of the
potential of quantitative phosphoproteomics to provide
unprecedented amounts of information about cellular signaling
from a single set of experiments.
A second example of the application of quantitative phos-
phoproteomics to the analysis of the dynamics of signaling
complexes involves the ERK/p90rsk protein kinase signaling
cassette [28]. This study utilized immunoprecipitation of
epitope-tagged versions of extracellular signal-regulated
protein kinase (ERK), p90 ribosomal S6 kinase (p90rsk), and
their targets, the tumor suppressors TSC1 and TSC2, to
profile phosphorylation of multiple sites on these proteins
simultaneously following either EGF stimulation or treat-
ment with the protein kinase C (PKC) activator phorbol
myristate acetate (PMA). New results from this study
include the discovery of a novel phosphorylation site in
p90rsk and eight novel phosphorylation sites in TSC1 and
TSC2. Selective kinase inhibitors were used to show that
phosphorylation of one of the novel sites in TSC2 was depen-
dent on the activation of PKC but independent of ERK. The
results demonstrated the existence of a previously uncharac-
terized PKC-dependent pathway for the regulation of TSC2.
Quantitative phosphoproteomic methods have also been
used for a large-scale analysis of yeast phosphoproteins
altered in response to activation of the mating pheromone-
response pathway. SILAC labeling was coupled with phos-
phopeptide enrichment to identify 729 phosphorylation sites
in 503 proteins [14]. Of these, 139 sites were altered follow-
ing pheromone treatment. Large numbers of phosphopep-
tides were derived from proteins known to be involved in the
pheromone signaling pathway, including the pheromone
receptor, components of the MAP kinase pathway, transcrip-
tion factors, proteins involved in cell polarization, and pro-
teins that participate in the assembly of mating projections.
The identification of a set of pheromone-regulated phospho-
rylations on RNA-processing and -transport proteins sug-
gested that the pheromone pathway has a previously
unknown role in regulating mRNA metabolism. Overall, this
study provided an unprecedented comprehensive dataset
that quantifies pheromone-dependent changes in the phos-
phorylation of large numbers of individual phosphorylation
sites. This included the identification of many proteins not
previously known to be phosphorylated, as well as the iden-
tification of novel phosphorylation sites present in previ-
ously characterized phosphoproteins. The methods used are
applicable to the study of cellular signaling in a wide variety
of cell types and signaling paradigms. The large number of
individual phosphorylation events that can be quantitatively
interrogated using this approach will provide a powerful
method for analyzing signaling networks at the systems
biology level.
In conclusion, mass-spectrometry-based phosphoproteomics
has already made significant contributions to our understand-
ing of cellular signaling. The incorporation of technological
advances in mass spectrometry and the application of novel
protein and peptide enrichment techniques will increase the
sensitivity and accuracy of detecting phosphoproteins and
identifying phosphorylation sites. Continued application of
quantitative methods will enhance the usefulness of data
derived from phosphoproteomic experiments. Owing to the
importance of reversible phosphorylation as a signal transduc-
tion mechanism, phosphoproteomics is likely to play an
increasingly valuable role in the study of cellular signaling.
This will be especially true as research in cellular signaling
begins to grapple with understanding context-dependent sig-
naling in living cells. Large-scale phosphoproteomic methods
have the potential to monitor information flow through large
portions of signaling networks that ultimately control the
overall response of a cell to changes in its environment. 
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